Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on 4D Medical.
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: Broad-based whinging leads ASX back to the start of 2023, minus the hope and ignorance
News
In Case You Missed It: Lithium exploration licences and Medicare reimbursement for US medtech play
Health & Biotech
ASX Health Stocks: 4DX skyrockets 54pc after US update on its XV LVAS scanning device
News
10 at 11ish: 4D Medical gets US tick, First Lithium bounces on Blakala update
Health & Biotech
ASX Health Stocks: Medibio jumps 50pc on Phase 1 results; Cann doubles cannabis harvest
Health & Biotech
4D Medical’s technology disrupts century-old procedures AND makes over 90pc profit margin
Health & Biotech
ScoPo’s Powerplays: ASX health stocks… could be worse
Experts
CRITERION: This ASX biotech is the sole dedicated player in a new $420 billion market
Health & Biotech
Check Up: Here’s how diabetes drugs can help you get off the beers and lose weight
Health & Biotech
ASX Health Stocks: 4DMedical makes breakthrough, potentially disrupts century-old method
Health & Biotech
ASX Health Stocks: Imugene’s liver cancer platform presented at prestigious conference
News
CLOSING BELL: The battle to claw back from -0.5% ended in a draw, so we have to come back tomorrow
News
CLOSING BELL: And with one swift tug, we all get to learn what it’s like to be pantsed by the RBA
News
Top 10 at 10: Big $$ deals, carmaker snaps up nickel-cobalt offtake
Health & Biotech
